The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Conditions
- Systemic Lupus Erythematosus
Interventions
- DRUG: Enpatoran low dose
- DRUG: Enpatoran medium dose
- DRUG: Enpatoran high dose
- DRUG: Placebo
Sponsor
EMD Serono Research & Development Institute, Inc.
Collaborators